BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 71573)

  • 1. Prolactin control in Huntington's chorea.
    Müller EE; Cocchi D; Mantegazza P; Parati EA; Caraceni T
    Lancet; 1977 Oct; 2(8041):764-5. PubMed ID: 71573
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired prolactin release in Huntington's chorea. Evidence for dopaminergic excess.
    Hayden MR; Vinik AI; Paul M; Beighton P
    Lancet; 1977 Aug; 2(8035):423-6. PubMed ID: 70642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone and prolactin secretion in Huntington's disease.
    Levy CL; Carlson HE; Sowers JR; Goodlett RE; Tourtellotte WW; Hershman JM
    Life Sci; 1979 Feb; 24(8):743-9. PubMed ID: 155768
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of sulpiride on prolactin release by rat pituitaries in vitro.
    Debeljuk L; Daskal H; Rozados R; Guitelman A
    Experientia; 1974 Nov; 30(11):1355-6. PubMed ID: 4215673
    [No Abstract]   [Full Text] [Related]  

  • 5. Stimulation of human prolactin secretion by sulpiride.
    Kato Y; Ohgo S; Chihara K; Imura H
    Endocrinol Jpn; 1975 Oct; 22(5):457-60. PubMed ID: 813995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin secretion response to TRH stimulation in acute and chronic schizophrenic patients under neuroleptic treatment.
    Cabranes JA; Fuentenebro F; Recio MN; Borque M; Almoguera MI
    Int Pharmacopsychiatry; 1982; 17(1):1-7. PubMed ID: 6123489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bovine posterior pituitary extract stimulates prolactin release from the anterior pituitary gland in vitro and in vivo in cattle.
    Hashizume T; Sasaki T; Nonaka S; Hayashi T; Takisawa M; Horiuchi M; Hirata T; Kasuya E
    Reprod Domest Anim; 2005 Apr; 40(2):184-9. PubMed ID: 15819972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma prolactin and GH response after thyrotropin-releasing hormone (TRH), L-DOPA and sulpiride in patients with senile dementia of Alzheimer type].
    Fujita M; Toyoda K; Motomura N; Kuroda K; Shimizu T
    Rinsho Shinkeigaku; 1985 Jul; 25(7):767-75. PubMed ID: 3935351
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
    Christian HC; Chapman LP; Morris JF
    J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin secretion in Parkinson disease.
    Eisler T; Thorner MO; MacLeod RM; Kaiser DL; Calne DB
    Neurology; 1981 Oct; 31(10):1356-9. PubMed ID: 6810204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrinologic findings in patients with untreated Huntington's chorea.
    Caraceni TA; Parati EA; Giovannini PM; Grassi MP; Scigliano G; Carella F; Müller EE
    Arch Neurol; 1984 May; 41(5):516-20. PubMed ID: 6232913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin secretion in chronic schizophrenia.
    Brambilla F; Guastalla A; Guerrini A; Rovere C; Legnani G; Sarno M; Riggi F
    Acta Psychiatr Scand; 1976 Oct; 54(4):275-86. PubMed ID: 826121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolactin response to chlorpromazine and thyrotropin-releasing hormone in hyperthyroidism.
    Onishi T; Miyai K; Izumi K; Nakanishi H; Kumahara Y
    J Clin Endocrinol Metab; 1975 Jan; 40(1):30-2. PubMed ID: 803513
    [No Abstract]   [Full Text] [Related]  

  • 14. Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.
    Russell SH; Kim MS; Small CJ; Abbott CR; Morgan DG; Taheri S; Murphy KG; Todd JF; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2000 Dec; 12(12):1213-8. PubMed ID: 11106980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone releasing activity of thyrotropin-releasing hormone in rats with hypothalamic lesions.
    Müller EE; Panerai AE; Cocchi D; Gil-Ad I; Rossi GL; Olgiati VR
    Endocrinology; 1977 Jun; 100(6):1663-71. PubMed ID: 404131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain immunoreactive gonadotropin-releasing hormone in Huntington's chorea and in non-choreic subjects.
    Bird ED; Chiappa SA; Fink G
    Nature; 1976 Apr; 260(5551):536-8. PubMed ID: 131252
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential ability of thyrotropin-releasing hormone and N3im-methyl-thyrotropin-releasing hormone to affect prolactin and thyrotropin production in primary rat pituitary cell cultures.
    Dannies PS; Markell MS
    Endocrinology; 1980 Jan; 106(1):107-12. PubMed ID: 6765928
    [No Abstract]   [Full Text] [Related]  

  • 18. Dopamine: a prolactin-inhibiting hormone.
    Ben-Jonathan N
    Endocr Rev; 1985; 6(4):564-89. PubMed ID: 2866952
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional evaluation of prolactin secretion: a guide to therapy.
    Friesen H; Guyda H; Hwang P; Tyson JE; Barbeau A
    J Clin Invest; 1972 Mar; 51(3):706-9. PubMed ID: 4622109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin releasing effect of sulpiride isomers in rats and man.
    Müller EE; Stefanini E; Camanni F; Locatelli V; Massara F; Spano PF; Cocchi D
    J Neural Transm; 1979; 46(3):205-14. PubMed ID: 528995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.